GenoVive
GenoVive, founded in 2008 in New Orleans, offers personalized weight management solutions based on genetics, serving consumers seeking DNA-tailored diet and lifestyle programs. The company currently shows signs of operational dormancy.
- Company typePrivate
- Founded2012
- HeadquartersNew Orleans, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What GenoVive does
GenoVive is a private, for-profit consumer genetics company founded in 2008 and headquartered in New Orleans, United States. Its stated value proposition is personalized weight management solutions based on genetics — DNA-derived insights intended to tailor diet and lifestyle recommendations to individual consumers rather than generic population-level diet plans. The firm operates at small-business scale per available firmographics (11–50 employees), and its primary web presence is genoviveusa.com.
The company was founded by Victor Castellon, who serves as Founder and CEO, with Paul Clinkscales as Chief Operating Officer. Beyond the genetic-personalization premise and this leadership pairing, the source data is notably thin: no products, pricing models, distribution channels, customer logos, partnerships, funding rounds, M&A activity, or regulatory actions are disclosed.
The most consequential signal in the current data set is operational rather than commercial: genoviveusa.com is listed for sale on the Domain Coasters marketplace, which is the strongest indicator in the inputs that the company's direct-to-consumer channel is not actively maintained. Pricing, customer-segment mix, and revenue mechanics are not stated, and should be treated as unknown until first-party operating data is sourced.
GenoVive firmographics
Firmographics- Name
- GenoVive
- Website
- https://genoviveusa.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Closed
- Headcount range
- 11–50 employees
- Short description
- GenoVive, founded in 2008 in New Orleans, offers personalized weight management solutions based on genetics, serving consumers seeking DNA-tailored diet and lifestyle programs. The company currently shows signs of operational dormancy.
- Ownership category
- akta.pro rank
GenoVive industry classification
Industry- Product category
- Personalized Weight Management
- NAICS
- Diet and Weight Reducing Centers (812191)
- akta.pro primary industry
- Population Genomics & Preventive Precision Health Programs (HLAAANAL)
- akta.pro secondary industries
- Weight Loss Coaching (Non-Clinical) (HSADAFAB), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), General Nutrition Coaching (HSADAFAA), Healthcare & Wellness Personalization (HDAAAGAI)
Keywords
Where GenoVive is headquartered
LocationHeadquarters
- HQ city
- New Orleans
- HQ country
- United States
- HQ region
- North America
Markets served
GenoVive business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
GenoVive product offering
Product offeringCore offering
GenoVive offers personalized weight management solutions based on genetics, providing DNA-driven diet and nutrition programs designed for individuals seeking tailored weight loss and wellness plans. The company combines genetic testing with customized nutritional guidance to deliver weight management services to consumers.
Product overview
No product or service information is available. The source data consists solely of a domain marketplace listing for genoviveusa.com being sold by Domain Coasters, containing no information about GenoVive's actual products, services, or technology offerings.
Differentiator
Problem solved
Functional benefit
Products and services
- Genetic-Based Weight Management Program
Companies that use GenoVive
Customer profileIdeal customer profiles1 record
GenoVive technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
GenoVive partnerships and signals
Strategic signalRecent moves1 record
GenoVive competitors and assessment
Company assessmentDirect peers
- Noom: Noom is a subscription weight-management app that uses psychology- and behavior-change-based personalization. While its personalization lever is psychological rather than genetic, it competes for the same consumer wallet share on personalized weight loss, including variants that incorporate biological inputs.
- Viome: Viome sells at-home test kits (microbiome and later genetics) that produce personalized nutrition and weight-management recommendations, directly mirroring GenoVive's DNA-based weight management concept. Both target health-conscious consumers with personalized dietary guidance derived from biological testing.
- Nutrigenomix: Nutrigenomix provides genetic tests that produce personalized dietary and weight-management recommendations for clinicians, dietitians, and consumers. The genetic testing-to-personalized-nutrition pipeline is essentially the same offering as GenoVive's, serving overlapping use cases in weight management.
Broad incumbents
- AncestryDNA: AncestryDNA is a mass-market consumer genetic testing service that, while ancestry-skewed, also offers trait and health-related reports that include diet and weight markers. It competes in the same consumer genetic-testing category GenoVive draws customers from.
- WW International (Weight Watchers): WW is the established incumbent in the weight-management category and has explored DNA-based personalization programs (e.g., partnerships with genetic testing providers). It represents the dominant scaled player GenoVive would need to differentiate against to win consumer attention.
- 23andMe: 23andMe is a large, established DTC genetic testing platform whose health + trait reports include weight, nutrition, and fitness-related genetic markers. It is a broad incumbent in the consumer genetics space that competes directly with GenoVive for mindshare among consumers seeking DNA-based wellness insights.
Emerging players
- Everlywell: Everlywell sells at-home health and wellness tests directly to consumers, spanning hormones, metabolism, and increasingly genetics-adjacent offerings. It competes for the same consumer base pursuing personalized, test-driven wellness programs.
- Habit (formerly): Habit offered a personalized nutrition testing kit (DNA + blood biomarkers) to drive individualized meal plans, conceptually identical to GenoVive's value proposition. It is a historical direct analog whose trajectory is informative for GenoVive's positioning.
- Helix: Helix operates a consumer-genomics platform and marketplace for DNA-powered apps, including nutrition and wellness applications. It is comparable as an enabling infrastructure / adjacent competitor for the same genomics-meets-wellness end market GenoVive targets.
- DayTwo: DayTwo provides personalized nutrition and blood-sugar management recommendations using gut-microbiome and genetic inputs. It overlaps with GenoVive on biological-data-driven weight and nutrition personalization, though anchored more to glycemic outcomes.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat2 records
Key risks4 records
Key highlights4 records
Customer concentration
GenoVive social profiles
Digital presenceGenoVive financial estimates
Financial estimateRevenue estimate
Valuation estimate
GenoVive leadership team
Management profileNumber of profiles
Profiles2 records
GenoVive funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
GenoVive M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about GenoVive
What does GenoVive do?
GenoVive offers personalized weight management solutions based on genetics, providing DNA-driven diet and nutrition programs designed for individuals seeking tailored weight loss and wellness plans. The company combines genetic testing with customized nutritional guidance to deliver weight management services to consumers.
When was GenoVive founded?
GenoVive was founded in 2012. It employs 11 to 50 people.
Where is GenoVive based?
GenoVive is headquartered in New Orleans, United States, in the North America region.
Who are GenoVive's main competitors?
Direct peers on record are Noom, Viome and Nutrigenomix. Broad incumbents are AncestryDNA, WW International (Weight Watchers) and 23andMe. Emerging players are Everlywell, Habit (formerly), Helix and DayTwo.
Does GenoVive have an API?
No public API is recorded for GenoVive.
What industry is GenoVive in?
GenoVive's product category is Personalized Weight Management. Its primary akta.pro industry code is HLAAANAL, Population Genomics & Preventive Precision Health Programs, with a secondary code of HSADAFAB, Weight Loss Coaching (Non-Clinical). Its NAICS code is 812191.